Employee Health and Priority Access to Providers
In today’s fast-paced and competitive business landscape, companies are increasingly recognizing the importance of employee well-being as a key driver of productivity, engagement, and talent retention. One innovative approach that has garnered attention is...
The Rotten Underbelly of PSA Testing and Prostate Cancer Surgery
Prostate cancer detection and treatment remain very controversial subjects. However, there are two earth-shattering books packed with facts that will empower you so you don’t become another sorry statistic injured during the prostate cancer testing and treatment...
Is Robotic Prostatectomy Bad Medicine?
Robotic prostatectomy remains a very controversial procedure – even amongst urologists. Prostate cancer surgery had its origins over 100 years ago when experimental trial and error surgery was permitted. In the 1980s this treatment philosophy for prostate cancer...
5 Challenges to Conventional Wisdom in Prostate Cancer
Patients with prostate cancer have a right to expect that their screening, diagnosis, and treatment are supported by evidence-based science. But how well does the urology community measure up when it comes to claims that standard-of-care practices are evidence-based?...
PSA TESTING, ACTIVE SURVEILLANCE AND MORE DAMNED LIES
Bert Vorstman, MD
PSA testing and prostate cancer management remain controversial. In recognition of the fact that many prostate cancer treatments are harmful and that many low-risk prostate cancers can be outlived without intervention, a less hurried active surveillance program was...
Is PSA and Prostate Cancer Advice Supported by Clinical Evidence?
Physicians have promoted PSA testing, prostate cancer detection and prostate cancer treatment to be safe, effective and potentially life-saving. A so-called standard-of-care favored with FDA approvals and “evidence-based” guidelines for managing localized prostate...